Akanda (AKAN) Common Equity (2020 - 2025)
Akanda (AKAN) posted quarterly Common Equity of -$12.0 million for Q4 2025, down 380.38% year-over-year from $4.3 million in Q4 2024, and down 463.21% quarter-over-quarter from $3.3 million in Q2 2025.
Akanda (AKAN) Common Equity (2020 - 2025) Analysis & Trends
Akanda's Common Equity history runs 6 years deep, the most recent figure standing at -$12.0 million for Q4 2025.
- In Q4 2025, Common Equity fell 380.38% year-over-year to -$12.0 million; the TTM figure through Dec 2025 stood at -$12.0 million (down 380.38% YoY), while the FY2025 annual figure was -$12.0 million, down 380.38% from the prior year.
- Common Equity for Q4 2025 stood at -$12.0 million, down from $3.3 million in the prior quarter.
- The five-year high for Common Equity was $50.2 million in Q2 2023, with the low at -$12.0 million in Q4 2025.
- The 5-year median for Common Equity is $3.8 million (2024), against an average of $11.1 million.
- The sharpest annual moves came in 2022 and 2025: Common Equity soared 1321.94% in 2022, then plunged 380.38% in 2025.
- Akanda's Common Equity stood at -$2.2 million in 2021, then jumped by 1321.94% to $26.9 million in 2022, then slumped by 114.23% to -$3.8 million in 2023, then soared by 211.69% to $4.3 million in 2024, then slumped by 380.38% to -$12.0 million in 2025.
- Business Quant data shows AKAN's Common Equity at -$12.0 million in Q4 2025, $3.3 million in Q2 2025, and $4.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Akanda | 267,946.09 | 267,946.09 | - | -11.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.99 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Dec 31, 2024 | 4.28 Mn |
| Jun 30, 2024 | 4.57 Mn |
| Dec 31, 2023 | -3.83 Mn |
| Jun 30, 2023 | 50.19 Mn |
| Dec 31, 2022 | 26.90 Mn |
| Jun 30, 2022 | 47.10 Mn |
| Dec 31, 2021 | -2.20 Mn |
| Jun 30, 2021 | -6.89 Mn |
| Dec 31, 2020 | -5.03 Mn |